Litigation Details for GALEPHAR PHARMACEUTICAL RESEARCH, INC. v. UPSHER-SMITH LABORATORIES, LLC (D.N.J. 2019)
✉ Email this page to a colleague
GALEPHAR PHARMACEUTICAL RESEARCH, INC. v. UPSHER-SMITH LABORATORIES, LLC (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-01-29 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-09-04 |
| Cause | 35:271 Patent Infringement | Assigned To | Madeline Cox Arleo |
| Jury Demand | None | Referred To | Michael A. Hammer |
| Parties | UPSHER-SMITH LABORATORIES, LLC | ||
| Patents | 7,435,427; 8,367,102; 8,952,064; 9,078,925; 9,089,534 | ||
| Attorneys | GREGORY D. MILLER | ||
| Firms | Rivkin Radler LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in GALEPHAR PHARMACEUTICAL RESEARCH, INC. v. UPSHER-SMITH LABORATORIES, LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for GALEPHAR PHARMACEUTICAL RESEARCH, INC. v. UPSHER-SMITH LABORATORIES, LLC (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-01-29 | 1 | United States Patent Nos. 7,435,427 (the “’427 patent”); 8,367,102 (the “’102 patent”); 8,952,064 (the…an act of infringement of U.S. Patent No. 7,435,427 (“the ’427 patent”) under 35 U.S.C. § 271(e)(2)(A… COUNT I (Infringement of U.S. Patent No. 7,435,427 Under 35 U.S.C. § 271(e)(2)(A) by Upsher…(the “’064 patent”); 9,078,925 (the “’925 patent”); and 9,089,534 (the “’534 patent,” collectively, the…’427 patent. B. The ’102 Patent 26. On February 5, 2013, the ’102 patent, entitled | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
